Phase i NIST sbir project, zymosense built and demonstrated feasibility of a screening tool that uses an automated pipettor to test a large number (96) of small (500ÌL) ATP systems in parallel
Ended Cooperative Agreement Awarded Last action
- Award ID
- 70NANB22H133
- Recipient
-
Zymosense Inc. UEI NLLSAWVUE3M7
- Awarding agency
-
National Institute of Standards and Technology
Department of Commerce
- Obligated
- $800,000
Award facts
- Assistance listing
- 11.620 Science, Technology, Business and/or Education Outreach
- Completion date
- Place of performance
- Ames, IA 50010, USA
Award details come from USAspending.gov.
About this award
The National Institute of Standards and Technology awarded Zymosense Inc. a $800,000 Cooperative Agreement under the Science, Technology, Business and/or Education Outreach federal grant program (CFDA 11.620) for the period of September 1, 2022 through August 31, 2024.
Under this award, Zymosense will optimize its automated pipetting screening tool for assessing single-walled carbon nanotube dispersion and separation processes. In Phase I, the company demonstrated the feasibility of using the tool to rapidly test 96 small ATP systems in parallel to map partition behavior at finer resolutions than possible manually. In Phase II, Zymosense will use the screening tool for customer-facing process optimization work, first testing improved separation quality and yield increases internally before licensing the methodology commercially to SWCNT manufacturers. The company also intends to provide a subaward of $TBD to the University of Iowa to receive training in machine learning and Bayesian optimization techniques to further enhance the screening tool. The work under this Cooperative Agreement aims to develop an additive SWCNT purification method with commercial applications for sensors, diagnostics and electronics.
Description
- Activities
- The following activities will be performed in phase II.1. Demonstrate improved separation quality by manipulating process steps, polymer concentration, and temperature.2. Improve yield by aggregate prevention and recovery.3. Apply process to customer-identified stocks and prototype purified nanoparticles for beta testing.
- Expected outcomes
- The optimal outcome will be an additive method of improving performance involving better dispersion of swcnt feedstocks as an alternative to subtractive (yield- reducing) methods that aim to remove more-challenging swcnt bundles.
- Intended beneficiaries
- Swcnt producers who are currently selling swcnt mixtures into r & d and application-oriented markets and eventually, the enriched swcnt will be sold to consumers for use in advanced sensors, diagnostics, filtration membranes, and electronics.
- Subrecipient activities
- The recipient intends to provide a subaward to the university of iowa chemical and biological engineering program. The university will help train the zymosense team in machine learning and bayesian optimization for active learning techniques.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $400,000 | |
| Original award | $400,000 |
Quick answers
Who received award 70NANB22H133?
70NANB22H133 was awarded to Zymosense Inc. by National Institute of Standards and Technology (Department of Commerce) on September 1, 2022.
How much is award 70NANB22H133 worth?
$800,000 has been obligated on 70NANB22H133.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award